Results 51 to 60 of about 2,727 (172)

Neck‐vein thrombosis during spaceflight

British Journal of Clinical Pharmacology, Volume 92, Issue 1, Page 24-34, January 2026.
Spaceflight imposes unique environmental challenges, including weightlessness, increased radiation exposure and confinement, which can lead to unexpected health effects. One such example is neck‐vein thrombosis, a condition rarely seen on Earth without predisposing factors such as venous catheters or infections.
Ulrich Limper, Jens Jordan
wiley   +1 more source

Exposure the Hazardous Potential of Quinalphos: An In‐Depth Analysis for Environmental and Biological Effects on Human Health

IET Systems Biology, Volume 20, Issue 1, January/December 2026.
This study elucidates pesticide docking onto proteins encoded by differentially expressed genes, revealing interaction networks involving chemicals, genes, proteins, drugs and diseases. It highlights structural insights, regulatory pathways and potential therapeutic or environmental implications, providing a comprehensive understanding of the ...
Jyoti Kant Choudhari, Biju Prava Sahariah, Anand Kumar Jayapal, Jyotsna Choubey, Abhishek Tripathi   +4 more
wiley   +1 more source

S3 Guideline for the treatment of psoriasis vulgaris, adapted from EuroGuiDerm – part 1: Treatment recommendations and monitoring

JDDG: Journal der Deutschen Dermatologischen Gesellschaft, Volume 24, Issue 1, Page 122-137, January 2026.
Summary This first part of the updated German S3 guideline on the treatment of psoriasis vulgaris covers the sections on treatment recommendations, treatment goals, and monitoring of therapies. The recommendations are based on the current Cochrane network meta‐analysis, the results of which are also summarized.
Alexander Nast, Andreas Altenburg, Matthias Augustin, Frank Bachmann, Wolf‐Henning Boehncke, Markus Cornberg, Hilte Geerdes‐Fenge, Brit Häcker, Peter Härle, Joachim Klaus, Michaela Köhm, Arno Köllner, Ulrich Mrowietz, Hans‐Michael Ockenfels, Antonia Pennitz, Sandra Philipp, Thomas Richter, Thomas Rosenbach, Tom Schaberg, Martin Schlaeger, Gerhard Schmid‐Ott, Michael Sebastian, Karisa Thölken, Ralph von Kiedrowski, Uwe Willuhn, Christoph Zeyen   +25 more
wiley   +1 more source

The Management of Heavy Menstrual Bleeding After Percutaneous Coronary Intervention in a Woman of Reproductive Age

Frontiers in Pharmacology, 2019
Heavy menstrual bleeding (HMB), previously known as menorrhagia, is in place with heavy flow and longer lasting days of bleeding during menstrual period, sequentially leading to anemia.
Zhi-Chun Gu, Fang-Hong Shi, Jie Zhu, Fang Wan, Long Shen, Hao Li   +5 more
doaj   +1 more source

Round Table Discussion: Aesthetic Treatment Considerations for the Perimenopausal & Menopausal Patient

Journal of Cosmetic Dermatology, Volume 25, Issue 1, January 2026.
ABSTRACT Background Menopause is a normal feature of the female aging process that commonly occurs during the 6th decade of life. During perimenopause, many negative effects begin to occur affecting the skin that are associated with decreasing production of estrogen, progesterone, and testosterone.
Sabrina G. Fabi, Maya Firsowicz, Payvand Kamrani, Zoe D. Draelos, Steven H. Dayan   +4 more
wiley   +1 more source

Partially Expelled Necrotic Uterine Fibroid After Relugolix Combination Therapy: Case Report and Literature Overview on Adverse Effects of GnRH Antagonists

Case Reports in Obstetrics and Gynecology, Volume 2026, Issue 1, 2026.
Background and Clinical Significance Relugolix combination therapy (Relugolix CT) has emerged as an effective oral medical treatment for symptomatic uterine fibroids, offering an alternative to surgical interventions. While generally well tolerated, reports of adverse events beyond the common side effects are limited.
Laura Vona, Anna Pitsillidi, Guenter Noé, Stefano Bettocchi, Dan Martin   +4 more
wiley   +1 more source

Effect of norethisterone dose and duration in the management of abnormal uterine bleeding: a narrative review and case report

Drugs in Context
Abnormal uterine bleeding (AUB) is an acute/chronic variation in the normal menstrual cycle that affects adolescents, women of reproductive age and perimenopausal women.
Arun Madhab Boruah, Dibyendu Banerjee, Farendra Bhardwaj, Subash Mallya, Rajat Singal, Sugandha Sharma, Ashutosh Gautam   +6 more
doaj   +1 more source

The Biological Activity of Estrogen-Free Norethindrone

Experimental Biology and Medicine, 1965
Estrogen-free norethindrone (17alpha-ethynyl-17beta-hydroxyestr-4-en-3one) was synthesized and its estrogenic and antiestrogenic activity and fertility and spermatogenetic activity were studied. Norethindrone was found to be .3% as active as estrone by gavage and by subcutaneous injection by a mouse uterotrophic assay.
F A, KINCL, R I, DORFMAN
openaire   +2 more sources

A chewable low-dose oral contraceptive: a new birth control option?

Patient Preference and Adherence, 2012
Edith Weisberg1,21Sydney Centre for Reproductive Health Research, Research Division of Family Planning NSW, 2Department of Obstetrics and Gynaecology, Queen Elizabeth II Research Institute for Mothers and Infants, University of Sydney, Sydney ...
Weisberg E
doaj  

Prenatal Progestin Exposure Is Associated With Autism Spectrum Disorders

Frontiers in Psychiatry, 2018
We have previously reported that prenatal progestin exposure induces autism-like behavior in offspring through ERβ (estrogen receptor β) suppression in the brain, indicating that progestin may induce autism spectrum disorders (ASD). In this study, we aim
Ling Li, Min Li, Jianping Lu, Xiaohu Ge, Weiguo Xie, Zichen Wang, Xiaoling Li, Chao Li, Xiaoyan Wang, Yan Han, Yifei Wang, Liyan Zhong, Wei Xiang, Xiaodong Huang, Haijia Chen, Paul Yao, Paul Yao, Paul Yao   +17 more
doaj   +1 more source